Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.03 | 0.7 |
mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.15 | 0.7 |
mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.13 | 0.7 |
mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.029 | 0.7 |